Hepatitis C and HIV in incarcerated populations: Fights, bites, searches, and syringes!

Journal of the Association of Nurses in AIDS Care

Volumn 14, Issue 5 SUPPL., 2003, Pages 108S-115S

  Zalumas, Jacqueline C ^a,b   Rose, Carol Dawson ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SE AIDS Train and Education Center ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HCV; HIV; HIV HCV coinfection; Inmates

Indexed keywords

HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH SERVICE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL EDUCATION; NURSING; PRISON; PROPHYLAXIS; REVIEW; SCREENING; SYRINGE; TREATMENT PLANNING; VIRUS INFECTION; VIRUS TRANSMISSION; ARTICLE; ORGANIZATION AND MANAGEMENT; PRISONER; UNITED STATES;

HEALTH SERVICES NEEDS AND DEMAND; HEPATITIS C; HIV INFECTIONS; HUMANS; PRISONERS; PRISONS; UNITED STATES;

EID: 0642279424     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1177/1055329003255590     Document Type: Article

References (26)

1. Aach, R. D., Stevens, C. E., Hollinger, F. B., Mosley, J. W., Peterson, D. A., Taylor, P. E., et al. (1991). Hepatitis C virus infection in post-transfusion hepatitis: An analysis with first- and second-generation assays. New England Journal of Medicine, 325, 1325-1329.
2. Alter, H. J., Jett, B. W., Polito, A. J., Farci, P., Melpolder, C., Shih, J. W., et al. (1991). Analysis of the role of hepatitis C virus in transfusion-associated hepatitis. In F. B. Hollinger, S. M. Lemon, & H. S. Margolis (Eds.), Viral hepatitis and liver disease (pp. 396-402). Baltimore: Williams & Wilkins.
3. Alter, H. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341, 556-562.
4. Alter, H. J., & Seeff, L. B. (2000). Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome. Seminar in Liver Disease, 20, 17-35.
5. Association of State and Territorial Health Officials. (2000). Hepatitis C and incarcerated populations: The next wave for correctional health initiatives. Report funded by CDC, ASTHO.
6. Beck, A. J., Karberg, J. C., & Harrison, P. M. (2002). Prison and jail inmates at midyear 2001. In Bureau of Justice Statistics Bulletin (NCJ Publication No. 191702). Washington, DC: U.S. Department of Justice.
7. Centers for Disease Control and Prevention. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report, 47(RR-19), 1-39.
8. Coinfection with HIV and hepatitis: What the correctional professional needs to know. (2000). HIV Inside, 2, 1-12.
9. Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., & Nelson, K. E. (1996). Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, and human immunodeficiency and human T-lymphotropic viruses. American Journal of Public Health, 86, 665-661.
10. Hammett, T. M., Harmon, A. B., & Rhodes, W. (2002). The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. American Journal of Public Health, 92, 1789-1794.
11. Harrison, P. M., & Beck, A. J. (2002). Prisoners in 2001. In Bureau of Justice Statistics Bulletin (NCJ Publication No. 195189). Washington, DC: U.S. Department of Justice.
12. Hser, Y. I., Maglione, M., & Boyle, K. (1999). Validity of self-report of drug use among STD patients, ER patients, and arrestees. American Journal of Drug and Alcohol Abuse, 25, 81-91.
13. Levin, J., Bick, J., & Stubblefield, E. (2002). Recommendation for those on the front line against hepatitis C. HIV and Hepatitis Education Prison Project News Report, 5, 1-8.
14. Maruschak, L. M. (2002). HIV in Prisons, 2000. In Bureau of Justice Statistics Bulletin (NCJ Publication No. 196023). Washington, DC: U.S. Department of Justice.
15. National Institutes of Health. (2002). Consensus development conference statement: Management of hepatitis C. St. Louis, MO: Elsevier Science.
16. Nerenberg, R., Wong, M., & DeGroot, A. (2002). HCV in corrections: Frontline or backwater. HIV and Hepatitis Education Prison Project News, 5, 1-8.
17. Ray, S. C. (2001). Science and treatment of HIV and hepatitis C virus coinfection. Topics in HIV Medicine, 9, 11-16.
18. Satoor, S., & Raufman, J. P. (2001). Treatment of hepatitis C. Clinical Cornerstone, 3(6), 36-26.
19. Sherman, K. (2002). Diagnosis and management of the HCV/HIV-coinfected patient. AIDS Clinical Care, 14, 39-43.
20. Sulkowski, M. S., Mast, E. E., Seeff, L. B., Thomas, D. L. (2000). Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clinical Infectious Diseases, 30(Suppl. 1), 577-584.
21. Tulsky, J., Shaffer, K. P., & Currie, S. (2002, October). Risks and behaviors associated with hepatitis and the opportunities for health education. Paper presented at Inside-Out: Fostering Healthy Outcomes for the Incarcerated and Their Families, San Diego, CA.
22. U.S. Department of Justice. (1993). Survey of state prison inmates (NCJ Publication No. 136949). Washington, DC: Author.
23. U.S. Department of Labor. (1996). Occupational exposure to bloodborne pathogens, revised (OSHA 3127). U.S. Department of Labor, Occupational Safety and Health Administration.
24. U.S. Public Health Service. (2001). Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Morbidity and Mortality Weekly Report, 50(RR-11), 1-53.
25. Weinbaum, C., Lyerla, R., & Margolis, H. S. (2003). Prevention and control of infections with hepatitis viruses in correctional settings. Morbidity and Mortality Weekly Report, 52(RR-1), 1-36.
26. Wilson, D. J. (2002). Drug use, testing, and treatment in jails. In Bureau of Justice Statistics Special Report (NCJ Publication No. 179999). Washington, DC: U.S. Department of Justice.